Showing 45,301 - 45,320 results of 46,288 for search '(( 5 ((step decrease) OR (mean decrease)) ) OR ( 50 ((we decrease) OR (a decrease)) ))', query time: 1.42s Refine Results
  1. 45301

    Histological sections of fat grafts that were removed from the PBS-treated, low-dose, and high-dose EPO treated mice 15 week after fat transplantation. by Saher Hamed (359646)

    Published 2013
    “…Each bar represents the mean CD68-positive cells or MVD ± SD from five regions of interest in each fat graft from each treatment group at the end of the 15-week study period. …”
  2. 45302
  3. 45303
  4. 45304
  5. 45305
  6. 45306
  7. 45307

    S1 Data - by Renjie Wang (1986553)

    Published 2025
    “…Notably, moderate (D2) and severe (D3) drought treatments led to negative GD values. GD decreased by 23.79%, 114.85%, and 175.50% for D1, D2, and D3 treatments, respectively, while reductions of 40.00%, 73.33%, and 90.00% in GD were observed compared to the control (CK). …”
  8. 45308

    S3 Data - by Renjie Wang (1986553)

    Published 2025
    “…Notably, moderate (D2) and severe (D3) drought treatments led to negative GD values. GD decreased by 23.79%, 114.85%, and 175.50% for D1, D2, and D3 treatments, respectively, while reductions of 40.00%, 73.33%, and 90.00% in GD were observed compared to the control (CK). …”
  9. 45309

    S2 Data - by Renjie Wang (1986553)

    Published 2025
    “…Notably, moderate (D2) and severe (D3) drought treatments led to negative GD values. GD decreased by 23.79%, 114.85%, and 175.50% for D1, D2, and D3 treatments, respectively, while reductions of 40.00%, 73.33%, and 90.00% in GD were observed compared to the control (CK). …”
  10. 45310

    S5 Data - by Renjie Wang (1986553)

    Published 2025
    “…Notably, moderate (D2) and severe (D3) drought treatments led to negative GD values. GD decreased by 23.79%, 114.85%, and 175.50% for D1, D2, and D3 treatments, respectively, while reductions of 40.00%, 73.33%, and 90.00% in GD were observed compared to the control (CK). …”
  11. 45311

    S6 Data - by Renjie Wang (1986553)

    Published 2025
    “…Notably, moderate (D2) and severe (D3) drought treatments led to negative GD values. GD decreased by 23.79%, 114.85%, and 175.50% for D1, D2, and D3 treatments, respectively, while reductions of 40.00%, 73.33%, and 90.00% in GD were observed compared to the control (CK). …”
  12. 45312

    S4 Data - by Renjie Wang (1986553)

    Published 2025
    “…Notably, moderate (D2) and severe (D3) drought treatments led to negative GD values. GD decreased by 23.79%, 114.85%, and 175.50% for D1, D2, and D3 treatments, respectively, while reductions of 40.00%, 73.33%, and 90.00% in GD were observed compared to the control (CK). …”
  13. 45313

    S7 Data - by Renjie Wang (1986553)

    Published 2025
    “…Notably, moderate (D2) and severe (D3) drought treatments led to negative GD values. GD decreased by 23.79%, 114.85%, and 175.50% for D1, D2, and D3 treatments, respectively, while reductions of 40.00%, 73.33%, and 90.00% in GD were observed compared to the control (CK). …”
  14. 45314

    TAp63 and p53 mutants display reduced proliferation in basal layers and reduced differentiation in upper layers of tubercle remnants. by Boris Fischer (507766)

    Published 2014
    “…(F) Distribution of phenotypic strengths (n, normal; C1, intermediate; C2, strong) in lower jaw tubercles of wild-type, TAp63 mutant, p53 mutant and TAp63/p53 double mutant fish at an age of 50 days (upper panel) and 1 year (lower panel), determined via calcein staining (for example, see <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1004048#pgen-1004048-g008" target="_blank">Figure 8V,X</a>). …”
  15. 45315

    Ticagrelor treatment, but not clopidogrel treatment, induces the praroxonase-1 (PON1) message, increases tissue and serum PON1 protein, and mitigates atherosclerosis. by Hasseri Halim (6883436)

    Published 2019
    “…<p>Abbreviations: CTL, control; CLO, clopidogrel; TIC, ticagrelor; RNA-Seq, RNA sequencing using next generation sequencing; PON1, paraoxonase 1; A.U., arbitrary unit; N = 5 per group; Error bars, means ± SD, statistical analyses performed using one-way ANOVA test with Fisher’s multiple comparisons; <i>NS</i>, not statistically significant; *, P < 0.05; **, P < 0.01 <i>(See also <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0218934#pone.0218934.s005" target="_blank">S5 Fig</a>).…”
  16. 45316

    DataSheet1_A New Definition for Intracranial Compliance to Evaluate Adult Hydrocephalus After Shunting.PDF by Seifollah Gholampour (5154608)

    Published 2022
    “…<p>The clinical application of intracranial compliance (ICC), ∆V/∆P, as one of the most critical indexes for hydrocephalus evaluation was demonstrated previously. …”
  17. 45317

    Table_1_Durability of immune response after SARS-CoV-2 vaccination in patients with chronic liver disease.docx by Ruixin Song (15399459)

    Published 2023
    “…Within 30 days of booster immunization, the positive rates of nCoV NTAb and nCoV S-RBD in patients with CLD rapidly increased from 29.0% and 48.4% at the end of basic immunization to 95.2% and 90.5%, and maintained a high level (defined as the positive rate >50%) until 120 days when the positive rates of nCoV NTAb and nCoV S-RBD were still high at 79.5% and 87.2%, respectively. …”
  18. 45318

    Table_3_Durability of immune response after SARS-CoV-2 vaccination in patients with chronic liver disease.docx by Ruixin Song (15399459)

    Published 2023
    “…Within 30 days of booster immunization, the positive rates of nCoV NTAb and nCoV S-RBD in patients with CLD rapidly increased from 29.0% and 48.4% at the end of basic immunization to 95.2% and 90.5%, and maintained a high level (defined as the positive rate >50%) until 120 days when the positive rates of nCoV NTAb and nCoV S-RBD were still high at 79.5% and 87.2%, respectively. …”
  19. 45319

    Table_1_Practical Model to Optimize the Strategy of Adjuvant Postmastectomy Radiotherapy in T1-2N1 Breast Cancer With Modern Systemic Therapy.docx by Fei-Fei Xu (538090)

    Published 2022
    “…After a median follow-up of 69 months, the 5-year rate of DFS, BCSS, and LRR in the overall cohort was 90.2%, 97.4%, and 3.6%, respectively. …”
  20. 45320

    Table_2_Durability of immune response after SARS-CoV-2 vaccination in patients with chronic liver disease.docx by Ruixin Song (15399459)

    Published 2023
    “…Within 30 days of booster immunization, the positive rates of nCoV NTAb and nCoV S-RBD in patients with CLD rapidly increased from 29.0% and 48.4% at the end of basic immunization to 95.2% and 90.5%, and maintained a high level (defined as the positive rate >50%) until 120 days when the positive rates of nCoV NTAb and nCoV S-RBD were still high at 79.5% and 87.2%, respectively. …”